Serum levels of tumor markers and presence of human antimouse antibodies: implications for diagnosis and treatment with radiolabeled monoclonal antibodies.

Bouvier, J F; Pernod, J; Rivoire, M; Maiassi, N

Bouvier, J F; Pernod, J; Rivoire, M; Maiassi, N.

Affiliation

Bouvier JF; Centre Léon Berard, Lyon, France.

Cancer Detect Prev ; 13(3-4): 251-62, 1988.

Article in En | MEDLINE | ID: mdl-2468412

Subject(s)

Antibodies, Monoclonal; Biomarkers, Tumor/blood; Neoplasms/blood; Antibodies, Monoclonal/therapeutic use; Breast Neoplasms/diagnostic imaging; Breast Neoplasms/radiotherapy; Breast Neoplasms/therapy; Carcinoembryonic Antigen/immunology; Chorionic Gonadotropin/immunology; Chorionic Gonadotropin, beta Subunit, Human; Digestive System Neoplasms/diagnostic imaging; Digestive System Neoplasms/radiotherapy; Digestive System Neoplasms/therapy; Female; Humans; Injections, Intravenous; Male; Middle Aged; Ovarian Neoplasms/diagnostic imaging; Ovarian Neoplasms/radiotherapy; Ovarian Neoplasms/therapy; Peptide Fragments/immunology; Radionuclide Imaging; alpha-Fetoproteins/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Antibodies, Monoclonal / Neoplasms Type of study: Diagnostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Detect Prev Year: 1988 Document type: Article Affiliation country: France Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links